Inhibition of radiation-induced skin fibrosis with imatinib

References

• Abdollahi A, Li M, Ping G, Plathow C, Domhan S, Kiessling F, Lee LB, McMahon G, Grone HJ, Lipson KE. 2005. Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. The Journal of Experimental Medicine 201:925–935.
   PubMed Web of Science ®Google Scholar
• Akhmetshina A, Venalis P, Dees C, Busch N, Zwerina J, Schett G, Distler O, Distler JH. 2009. Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis. Arthritis and Rheumatism 60:219–224.
   PubMed Web of Science ®Google Scholar
• Anscher MS, Thrasher B, Zgonjanin L, Rabbani ZN, Corbley MJ, Fu K, Sun L, Lee WC, Ling LE, Vujaskovic Z. 2008. Small molecular inhibitor of transforming growth factor-beta protects against development of radiation-induced lung injury. International Journal of Radiation Oncology Biology Physics 71:829–837.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Ishida W, Wu M, Wilkes M, Mori Y, Hinchcliff M, Leof E, Varga J. 2009. A non-Smad mechanism of fibroblast activation by transforming growth factor-beta via c-Abl and Egr-1: Selective modulation by imatinib mesylate. Oncogene 28:1285–1297.
   PubMed Web of Science ®Google Scholar
• Bibi Y, Gottlieb AB. 2008. A potential role for imatinib and other small molecule tyrosine kinase inhibitors in the treatment of systemic and localized sclerosis. Journal of the American Academy of Dermatology 59:654–658.
   PubMed Web of Science ®Google Scholar
• Bonner JC. 2004. Regulation of PDGF and its receptors in fibrotic diseases. Cytokine & Growth Factor Reviews 15:255–273.
   PubMed Web of Science ®Google Scholar
• Bruna A, Darken RS, Rojo F, Ocana A, Penuelas S, Arias A, Paris R, Tortosa A, Mora J, Baselga J. 2007. High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell 11:147–160.
   PubMed Web of Science ®Google Scholar
• Brush J, Lipnick SL, Phillips T, Sitko J, McDonald JT, McBride WH. 2007. Molecular mechanisms of late normal tissue injury. Seminars in Radiation Oncology 17:121–130.
   PubMed Web of Science ®Google Scholar
• Choudhury A, Zhao H, Jalali F, Al Rashid S, Ran J, Supiot S, Kiltie AE, Bristow RG. 2009. Targeting homologous recombination using imatinib results in enhanced tumor cell chemosensitivity and radiosensitivity. Molecular Cancer Therapeutics 8:203–213.
   PubMed Web of Science ®Google Scholar
• Chung L, Fiorentino DF, Benbarak MJ, Adler AS, Mariano MM, Paniagua RT, Milano A, Connolly MK, Ratiner BD, Wiskocil RL. 2009. Molecular framework for response to imatinib mesylate in systemic sclerosis. Arthritis and Rheumatism 60:584–591.
   PubMed Web of Science ®Google Scholar
• Classen JF, Henrohn D, Rorsman F, Lennartsson J, Lauwerys BR, Wikstrom G, Rorsman C, Lenglez S, Franck-Larsson K, Tomasi JP. 2009. Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis. Arthritis and Rheumatism 60:1137–1144.
   PubMed Web of Science ®Google Scholar
• Czuwara-Ladykowska J, Gore EA, Shegogue DA, Smith EA, Trojanowska M. 2001. Differential regulation of transforming growth factor-beta receptors type I and II by platelet-derived growth factor in human dermal fibroblasts. The British Journal of Dermatology 145:569–575.
   PubMed Web of Science ®Google Scholar
• Distler JH, Jungel A, Huber LC, Schulze-Horsel U, Zwerina J, Gay RE, Michel BA, Hauser T, Schett G, Gay S. 2007. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. Arthritis and Rheumatism 56:311–322.
   PubMed Web of Science ®Google Scholar
• Flanders KC, Sullivan CD, Fujii M, Sowers A, Anzano MA, Arabshahi A, Major C, Deng C, Russo A, Mitchell JB. 2002. Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation. The American Journal of Pathology 160:1057–1068.
   PubMed Web of Science ®Google Scholar
• Flanders KC, Major CD, Arabshahi A, Aburime EE, Okada MH, Fujii M, Blalock TD, Schultz GS, Sowers A, Anzano MA. 2003. Interference with transforming growth factor-beta/ Smad3 signaling results in accelerated healing of wounds in previously irradiated skin. The American Journal of Pathology 163:2247–2257.
   PubMed Web of Science ®Google Scholar
• Gabrielli A, Svegliati S, Moroncini G, Luchetti M, Tonnini C, Avvedimento EV. 2007. Stimulatory autoantibodies to the PDGF receptor: A link to fibrosis in scleroderma and a pathway for novel therapeutic targets. Autoimmunity Reviews 7:121–126.
   PubMed Web of Science ®Google Scholar
• Garber K. 2009. Companies waver in efforts to target transforming growth factor beta in cancer. Journal of the National Cancer Institute 101:1664–1667.
   PubMedGoogle Scholar
• Herskind C, Bamberg M, Rodemann HP. 1998. The role of cytokines in the development of normal-tissue reactions after radiotherapy. Strahlentherapie und Onkologie 174(Suppl. 3):12–15.
   PubMed Web of Science ®Google Scholar
• Kay J, High WA. 2008. Imatinib mesylate treatment of nephrogenic systemic fibrosis. Arthritis and Rheumatism 58:2543–2548.
   PubMed Web of Science ®Google Scholar
• Kerkela R, Grazette L, Yacobi R, Iliescu C, Patten R, Beahm C, Walters B, Shevtsov S, Pesant S, Clubb FJ. 2006. Cardiotoxicity of the cancer therapeutic agent imatinib mesylate. Nature Medicine 12:908–916.
   PubMed Web of Science ®Google Scholar
• Li M, Abdollahi A, Grone HJ, Lipson KE, Belka C, Huber PE. 2009. Late treatment with imatinib mesylate ameliorates radiation-induced lung fibrosis in a mouse model. Radiation Oncology 4:66.
   PubMed Web of Science ®Google Scholar
• Li M, Ping G, Plathow C, Trinh T, Lipson KE, Hauser K, Krempien R, Debus J, Abdollahi A, Huber PE. 2006. Small molecule receptor tyrosine kinase inhibitor of platelet-derived growth factor signaling (SU9518) modifies radiation response in fibroblasts and endothelial cells. BMC Cancer 6:79.
   PubMed Web of Science ®Google Scholar
• Liu Y, Kudo K, Abe Y, Hu DL, Kijima H, Nakane A, Ono K. 2009. Inhibition of transforming growth factor-beta, hypoxia-inducible factor-1alpha and vascular endothelial growth factor reduced late rectal injury induced by irradiation. Journal of Radiation Research (Tokyo) 50:233–239.
   PubMed Web of Science ®Google Scholar
• Martin M, Lefaix J, Delanian S. 2000. TGF-beta1 and radiation fibrosis: A master switch and a specific therapeutic target?International Journal of Radiation Oncology, Biology, Physics 47:277–290.
   PubMed Web of Science ®Google Scholar
• Maurer B, Stanczyk J, Jungel A, Akhmetshina A, Trenkmann M, Brock M, Kowal-Bielecka O, Gay RE, Michel BA, Distler JH. 2010. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis and Rheumatism 62:1733–1743.
   PubMed Web of Science ®Google Scholar
• Molin J, Sogaard PE, Overgaard J. 1981. Experimental studies on the radiation-modifying effect of bleomycin in malignant and normal mouse tissue in vivo. Cancer Treatment Reports 65:583–589.
   PubMedGoogle Scholar
• Muller K, Meineke V. 2010. Advances in the management of localized radiation injuries. Health Physics 98:843–850.
   PubMed Web of Science ®Google Scholar
• Pan D, Yang J, Lu F, Xu D, Zhou L, Shi A, Cao K. 2007. Platelet-derived growth factor BB modulates PCNA protein synthesis partially through the transforming growth factor beta signalling pathway in vascular smooth muscle cells. Biochemistry and Cell Biology (Biochimie et biologie cellulaire) 85:606–615.
   PubMed Web of Science ®Google Scholar
• Panizzon RG, Malkinson FD, Hanson WR, Schwartz DE. 1986. A one-year comparative study of post-irradiation collagen content and microscopic fibrosis in mouse skin. British Journal of Radiology 19:54–57.
   Google Scholar
• Panizzon RG, Hanson WR, Schwartz DE, Malkinson FD. 1988. Ionizing radiation induces early, sustained increases in collagen biosynthesis: A 48-week study in mouse skin and skin fibroblast cultures. Radiation Research 116:145–156.
   PubMed Web of Science ®Google Scholar
• Ranza E, Bertolotti A, Facoetti A, Mariotti L, Pasi F, Ottolenghi A, Nano R. 2009. Influence of imatinib mesylate on radiosensitivity of astrocytoma cells. Anticancer Research 29:4575–4578.
   PubMed Web of Science ®Google Scholar
• Rodemann HP, Bamberg M. 1995. Cellular basis of radiation-induced fibrosis. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 35:83–90.
   PubMed Web of Science ®Google Scholar
• Russell JS, Brady K, Burgan WE, Cerra MA, Oswald KA, Camphausen K, Tofilon PJ. 2003. Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity. Cancer Research 63:7377–7383.
   PubMed Web of Science ®Google Scholar
• Stone HB. 1984. Leg contracture in mice: An assay of normal tissue response. International Journal of Radiation Oncology, Biology and Physics 10:1053–1061.
   PubMed Web of Science ®Google Scholar
• Thomas DM, Fox J, Haston CK. 2010. Imatinib therapy reduces radiation-induced pulmonary mast cell influx and delays lung disease in the mouse. International Journal of Radiation Biology 86:436–444.
   PubMed Web of Science ®Google Scholar
• Walsh BJ, Thornton SC, Penny R, Breit SN. 1992. Microplate reader-based quantitation of collagens. Analytical Biochemistry 203:187–190.
   PubMed Web of Science ®Google Scholar
• Wright EG, Coates PJ. 2006. Untargeted effects of ionizing radiation: Implications for radiation pathology. Mutation Research 597: 119–132.
   PubMed Web of Science ®Google Scholar
• Wynn TA. 2008. Cellular and molecular mechanisms of fibrosis. The Journal of Pathology 214:199–210.
   PubMed Web of Science ®Google Scholar
• Xavier S, Piek E, Fujii M, Javelaud D, Mauviel A, Flanders KC, Samuni AM, Felici A, Reiss M, Yarkoni S. 2004. Amelioration of radiation-induced fibrosis: Inhibition of transforming growth factor-beta signaling by halofuginone. The Journal of Biological Chemistry 279:15167–15176.
   PubMed Web of Science ®Google Scholar
• Yarnold J, Brotons MC. 2010. Pathogenetic mechanisms in radiation fibrosis. Radiotherapy and Oncology 97:149–161.
   PubMed Web of Science ®Google Scholar
• Yi ES, Bedoya A, Lee H, Chin E, Saunders W, Kim SJ, Danielpour D, Remick DG, Yin S, Ulich TR. 1996. Radiation-induced lung injury in vivo: Expression of transforming growth factor-beta precedes fibrosis. Inflammation 20:339–352.
   PubMed Web of Science ®Google Scholar
• Yoshida M, Sakuma J, Hayashi S, Abe K, Saito I, Harada S, Sakatani M, Yamamoto S, Matsumoto N, Kaneda Y. 1995. A histologically distinctive interstitial pneumonia induced by overexpression of the interleukin 6, transforming growth factor beta 1, or platelet-derived growth factor B gene. Proceedings of the National Academy of Sciences of the USA. 92:9570–9574.
   PubMed Web of Science ®Google Scholar